Skip to content

IN MOTHERS UNDERGOING DELIVERY BY OPERATION AND MAKING IT PAIN FREE BY GIVING INJECTION IN BACK, A STUDY IS BEING CONDUCTED AMONG 2 DRUGS WHICH ARE USED DURING THE OPERATION

COMPARISON OF PROPHYLACTIC LOW DOSE EPINEPHRINE AND PHENYLEPHRINE INFUSION ON MATERNAL HEMODYNAMICS DURING SPINAL ANAESTHESIA FOR ELECTIVE CESAREAN SECTION - A PROSPECTIVE, RANDOMIZED, DOUBLE BLIND STUDY - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/060333
Enrollment
150
Registered
2023-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ephedrine infusion: Group E, will receive an infusion of Epinephrine at a rate of 0.03 mcg/kg/min from the time of administration of spinal till the end of surgery in a 50 ml syringe pu

Sponsors

Office of the Principal, Midnapore Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients giving valid consent 2. All ASA criteria I and II 3. Elective LSCS 4. Patient between 18 to 35 years of age 5. Term singleton pregnancy

Exclusion criteria

Exclusion criteria: a. Patient’s refusal. b. Patients with medical complications like diabetes, CVA, cardio respiratory disease, hepatic, renal or endocrine disease. c. Obstetric complications like breech presentation, twin pregnancy, placenta previa, placental abruption, pregnancy induced hypertension (PIH). d. Patients with autonomic neuropathy, spinal deformity or coagulation abnormality. e. Patients with neonatal compromise like fetal bradycardia meconium stained liquor, IUGR. f. Failed spinal ,repeat spinal, patchy spinal, Conversion to general anesthesia at any moment of surgery is excluded from study. g. Patient with history of allergy to study drugs h. Height 180 cm i. Weight 100kg.

Design outcomes

Primary

MeasureTime frame
1. To monitor and record hemodynamic parameters like Heart rate, SBP,DBP,MAP at specific time intervals and compare between studies. 2. To record the incidence of bradycardia and hypotension episodes in both groups.Timepoint: baseline (0 min), 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min, 35 min, 40 min, 45 min, 50 min, 55 min, 60 min

Secondary

MeasureTime frame
Incidence of adverse effects like tachycardia, hypertension, intra operative nausea vomiting and complications if any.Timepoint: baseline (0 min), 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min, 35 min, 40 min, 45 min, 50 min, 55 min, 60 min;To compare the neonatal outcome between the two groups by measuring APGAR scores at one minute and five minute , umbilical cord blood gas analysis. Timepoint: 1 min, 5 min after baby delivery

Countries

India

Contacts

Public ContactDr Bijoy Kumar Bandyopadhyay

Midnapore Medical College and Hospital

bjoybnrjee@gmail.com9332132242

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026